• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中ASCL2表达升高与患者预后不良相关。

Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.

作者信息

Xu Hui, Zhao Xi-Long, Liu Xue, Hu Xu-Gang, Fu Wen-Juan, Li Qian, Wang Yan, Ping Yi-Fang, Zhang Xia, Bian Xiu-Wu, Yao Xiao-Hong

机构信息

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical UniversityChongqing 400038, China.

出版信息

Am J Cancer Res. 2017 Apr 1;7(4):955-961. eCollection 2017.

PMID:28469967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5411802/
Abstract

Achaete scute-like 2 (ASCL2) is a member of the basic helix-loop-helix (bHLH) transcription factors, and is expressed mainly in intestinal stem cells under normal conditions. Recently, aberrantly elevated ASCL2 was detected in cancer tissues, but the clinical relevance of ASCL2 in breast cancers remains to be decided. In this study, we evaluated the expression of ASCL2 and its relationship to cancer progression in specimens from 191 cases of breast cancer patients with follow-up information. The results indicated that ASCL2 was highly expressed in cancer cells while it was undetectable in normal epithelial cells. Moreover, the expression of ASCL2 was positively correlated with breast tumor size, lymphatic metastasis and the active growth of tumor cells as shown by increased expression of Ki67. Kaplan-Meier analysis revealed that patients with higher levels of ASCL2 suffered higher tumor recurrent rate. Multivariable Cox-regression analysis showed that elevated expression of ASCL2 was an independent and unfavorable indicator of tumor relapse in breast cancer patients. Altogether, our study suggests that ASCL2 defines a subgroup of highly progressive breast cancer and serves as a marker to evaluate the risk of cancer relapse.

摘要

achaete-scute 样 2(ASCL2)是碱性螺旋-环-螺旋(bHLH)转录因子家族的成员,在正常情况下主要在肠道干细胞中表达。最近,在癌组织中检测到 ASCL2 异常升高,但 ASCL2 在乳腺癌中的临床相关性仍有待确定。在本研究中,我们评估了 191 例有随访信息的乳腺癌患者标本中 ASCL2 的表达及其与癌症进展的关系。结果表明,ASCL2 在癌细胞中高表达,而在正常上皮细胞中未检测到。此外,ASCL2 的表达与乳腺肿瘤大小、淋巴转移以及肿瘤细胞的活跃生长呈正相关,Ki67 表达增加表明了这一点。Kaplan-Meier 分析显示,ASCL2 水平较高的患者肿瘤复发率较高。多变量 Cox 回归分析表明,ASCL2 表达升高是乳腺癌患者肿瘤复发的独立且不良指标。总之,我们的研究表明,ASCL2 定义了一组高度进展性乳腺癌亚组,并可作为评估癌症复发风险的标志物。

相似文献

1
Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.乳腺癌中ASCL2表达升高与患者预后不良相关。
Am J Cancer Res. 2017 Apr 1;7(4):955-961. eCollection 2017.
2
Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.临床癌症患者中achaete-scute复合体样基因特征的系统分析。
Mol Clin Oncol. 2017 Jan;6(1):7-18. doi: 10.3892/mco.2016.1094. Epub 2016 Nov 25.
3
Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.ASCL2表达升高是肺鳞状细胞癌的独立预后指标。
J Clin Pathol. 2016 Apr;69(4):313-8. doi: 10.1136/jclinpath-2015-203025. Epub 2015 Oct 19.
4
Elevated ASCL2 expression is associated with metastasis of osteosarcoma and predicts poor prognosis of the patients.ASCL2表达升高与骨肉瘤转移相关,并预示患者预后不良。
Am J Cancer Res. 2016 Jun 1;6(6):1431-40. eCollection 2016.
5
Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.achaete-scute 家族 bHLH 转录因子 2 的激活促进肝母细胞瘤的进展。
Cancer Sci. 2024 Mar;115(3):847-858. doi: 10.1111/cas.16051. Epub 2024 Jan 5.
6
Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia.achaete-scute 样 2(ascl2)是 Wnt 信号通路的一个靶点,在肠道肿瘤中上调。
Oncogene. 2006 Jun 8;25(24):3445-57. doi: 10.1038/sj.onc.1209382. Epub 2006 Mar 27.
7
Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation.无翅型基因同源物2抑制CDX2表达并抑制肠道肿瘤上皮细胞分化。
Oncotarget. 2015 Oct 13;6(31):30993-1006. doi: 10.18632/oncotarget.5206.
8
WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.年轻起病的分化型结肠癌中 WiNTRLINC1/ASCL2/c-Myc 轴的特征及其对细胞活力的重要性。
Ann Surg Oncol. 2019 Dec;26(13):4826-4834. doi: 10.1245/s10434-019-07780-3. Epub 2019 Sep 23.
9
Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells.启动子去甲基化导致 ASCL2 异常上调,促进胃癌细胞的生长和对 5- 氟尿嘧啶的耐药性。
Cancer Sci. 2013 Mar;104(3):391-7. doi: 10.1111/cas.12076. Epub 2013 Feb 14.
10
Achaete-scute complex-like 2 regulated inflammatory mechanism through Toll-like receptor 4 activating in stomach adenocarcinoma.Achaete-scute 同源物 2 通过激活胃癌中的 Toll 样受体 4 调节炎症机制。
World J Surg Oncol. 2022 Aug 25;20(1):266. doi: 10.1186/s12957-022-02722-y.

引用本文的文献

1
Mitigation of multi-scale biases in cell-type deconvolution for spatially resolved transcriptomics using HarmoDecon.使用HarmoDecon减轻空间分辨转录组学中细胞类型反卷积的多尺度偏差。
Bioinformatics. 2025 Sep 1;41(9). doi: 10.1093/bioinformatics/btaf451.
2
Unravelling NK cell subset dynamics and specific gene signatures post-ibrutinib therapy in chronic lymphocytic leukaemia via single-cell transcriptomics.通过单细胞转录组学揭示慢性淋巴细胞白血病患者接受依鲁替尼治疗后自然杀伤细胞亚群动态及特定基因特征。
BMC Cancer. 2025 Apr 21;25(1):745. doi: 10.1186/s12885-025-14166-0.
3
Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development.探索肿瘤免疫疗法在药物研发中的复杂性和前景。
Int J Mol Sci. 2024 Jun 11;25(12):6444. doi: 10.3390/ijms25126444.
4
A genomic mutational constraint map using variation in 76,156 human genomes.基于 76156 个人类基因组的变异,绘制出基因组突变约束图谱。
Nature. 2024 Jan;625(7993):92-100. doi: 10.1038/s41586-023-06045-0. Epub 2023 Dec 6.
5
Inferring regulators of cell identity in the human adult pancreas.推断人类成年胰腺中细胞身份的调节因子。
NAR Genom Bioinform. 2023 Jul 10;5(3):lqad068. doi: 10.1093/nargab/lqad068. eCollection 2023 Sep.
6
Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.识别和验证与侵袭相关的宫颈癌分子亚型和预后特征。
Comput Math Methods Med. 2022 Mar 18;2022:1902289. doi: 10.1155/2022/1902289. eCollection 2022.
7
Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma.miRNAs 作为肝细胞癌诊断和预后标志物的鉴定。
Aging (Albany NY). 2021 Feb 22;13(4):6115-6133. doi: 10.18632/aging.202606.
8
The Transcription Factor SCX is a Potential Serum Biomarker of Fibrotic Diseases.转录因子 SCX 是潜在的纤维化疾病血清生物标志物。
Int J Mol Sci. 2020 Jul 16;21(14):5012. doi: 10.3390/ijms21145012.
9
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.小细胞肺癌肿瘤和临床前模型表现出神经内分泌表型的异质性。
Transl Lung Cancer Res. 2018 Feb;7(1):32-49. doi: 10.21037/tlcr.2018.02.02.

本文引用的文献

1
Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.临床癌症患者中achaete-scute复合体样基因特征的系统分析。
Mol Clin Oncol. 2017 Jan;6(1):7-18. doi: 10.3892/mco.2016.1094. Epub 2016 Nov 25.
2
Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.ASCL2表达升高是肺鳞状细胞癌的独立预后指标。
J Clin Pathol. 2016 Apr;69(4):313-8. doi: 10.1136/jclinpath-2015-203025. Epub 2015 Oct 19.
3
SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.SEMA3F 通过下调 ASCL2-CXCR4 轴抑制结直肠癌细胞转移。
J Pathol. 2015 Aug;236(4):467-78. doi: 10.1002/path.4541. Epub 2015 May 22.
4
MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.achaete scute样蛋白2(Ascl2)对MicroRNA-200(miR-200)簇的调控:对结肠癌细胞上皮-间质转化的影响
J Biol Chem. 2014 Dec 26;289(52):36101-15. doi: 10.1074/jbc.M114.598383. Epub 2014 Nov 4.
5
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
6
Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis.胃肿瘤发生早期LGR5+细胞的分布及相关影响
PLoS One. 2013 Dec 10;8(12):e82390. doi: 10.1371/journal.pone.0082390. eCollection 2013.
7
Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells.启动子去甲基化导致 ASCL2 异常上调,促进胃癌细胞的生长和对 5- 氟尿嘧啶的耐药性。
Cancer Sci. 2013 Mar;104(3):391-7. doi: 10.1111/cas.12076. Epub 2013 Feb 14.
8
In situ validation of an intestinal stem cell signature in colorectal cancer.在结直肠癌中验证肠干细胞特征。
Gut. 2013 Jul;62(7):1012-23. doi: 10.1136/gutjnl-2011-301195. Epub 2012 May 25.
9
Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.Ascl2 敲低通过 miRNA-302b 相关抑制结肠癌细胞祖细胞导致肿瘤生长停滞。
PLoS One. 2012;7(2):e32170. doi: 10.1371/journal.pone.0032170. Epub 2012 Feb 23.
10
Chemokine receptor CXCR4 level in primary tumors independently predicts outcome for patients with locally advanced breast cancer.原发肿瘤中趋化因子受体 CXCR4 的水平独立预测局部晚期乳腺癌患者的预后。
Surgery. 2011 Sep;150(3):459-65. doi: 10.1016/j.surg.2011.07.005.